N-Acetylleucine
|
Basic information |
| Metabolite name | N-Acetylleucine |
 | HMDB0011756 |
 |
C02710 |
 |
70912 |
| Synonyms | N-acetyl-L-leucine; |
| No. of studies | 9 |
|
Basic information |
| Metabolite name | N-Acetylleucine |
| HMDB0011756 |
|
C02710 |
|
70912 |
| Synonyms | N-acetyl-L-leucine; |
| No. of studies | 9 |
|
Relationship between N-Acetylleucine and depression (count: 9) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M083 | Type1 | CUMS group vs. control group | Prefrontal cortex | Sprague-Dawley rat | Down |
| Study M1072 | Type1 | CUMS group vs. control group | Intestine | Cynomolgus monkey | Up |
| Study M1090 | Type2 | CUMS + hyperbaric oxygen treatment group vs. CUMS group | Plasma | BALb/c mouse | Up |
| Study M110 | Type1 | SD group vs. control group | Prefrontal cortex | Sprague-Dawley rat | Up |
| Study M119 | Type1 | LH group vs. control group | Prefrontal cortex | Sprague-Dawley rat | Down |
| Study M463 | Type3 | venlafaxine group vs. control group | Prefrontal cortex | C57BL/6J mouse | Down |
| Study M540 | Type1 | CUMS group vs. control group | Hippocampus | Sprague-Dawley rat | Up |
| Study M846 | Type1 | postpartum depression model group vs. control group | Faece | BALB/c mouse | Up |
| Study M850 | Type1 | reserpine group vs. control group | Brain | C57BL/6 mouse | Down |